The DOI matches its Crossref record; 208 of the 208 references it cites were found in a registry or an index.
Azithromycin: Mechanisms of action and their relevance for clinical applications
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock
Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., Jaeschke, R., et al. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e31827e83af · Cited by 9,694
The Surviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup*, Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., et al. (2013) · Intensive Care Medicine · doi:10.1007/s00134-012-2769-8 · Cited by 7,290
Immunosuppression in Patients Who Die of Sepsis and Multiple Organ Failure
Boomer, J. S., To, K., Chang, K. C., Takasu, O., Osborne, D. F., Walton, A. H., Bricker, T. L., Jarman, S. D., Kreisel, D., Krupnick, A. S., et al. (2011) · JAMA · doi:10.1001/jama.2011.1829 · Cited by 1,781
Azithromycin for prevention of exacerbations of COPD
Albert, R. K., Connett, J., Bailey, W. C., Casaburi, R., Cooper, J. A. D., Criner, G. J., Curtis, J. L., Dransfield, M. T., Han, M. K., Lazarus, S. C., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1104623 · Cited by 1,226
Leclercq, R. (2002) · Clinical Infectious Diseases · doi:10.1086/324626 · Cited by 1,102
STRUCTURE AND FUNCTION OF THE MANNOSE 6-PHOSPHATE/INSULINLIKE GROWTH FACTOR II RECEPTORS
Kornfeld, S. (1992) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.61.070192.001515 · Cited by 1,092
Saiman, L., Marshall, B. C., Mayer-Hamblett, N., Burns, J. L., Quittner, A. L., Cibene, D. A., Coquillette, S., Fieberg, A. Y., Accurso, F. J., Campbell III, P. W., et al. (2003) · JAMA · doi:10.1001/jama.290.13.1749 · Cited by 958
Azithromycin and the Risk of Cardiovascular Death
Ray, W. A., Murray, K. T., Hall, K., Arbogast, P. G., & Stein, C. M. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1003833 · Cited by 954
The pharmacokinetics of azithromycin in human serum and tissues
Foulds, G., Shepard, R. M., & Johnson, R. B. (1990) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/25.suppl_a.73 · Cited by 755
Mechanisms of Action and Clinical Application of Macrolides as Immunomodulatory Medications
Kanoh, S., & Rubin, B. K. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00078-09 · Cited by 708
Wong, C., Jayaram, L., Karalus, N., Eaton, T., Tong, C., Hockey, H., Milne, D., Fergusson, W., Tuffery, C., Sexton, P., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60953-2 · Cited by 600
Improvement of Survival in Patients with Diffuse Panbronchiolitis Treated with Low-dose Erythromycin
KUDOH, S., AZUMA, A., YAMAMOTO, M., IZUMI, T., & ANDO, M. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.6.9710075 · Cited by 582
The Structures of Four Macrolide Antibiotics Bound to the Large Ribosomal Subunit
Hansen, J. L., Ippolito, J. A., Ban, N., Nissen, P., Moore, P. B., & Steitz, T. A. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00570-1 · Cited by 568
Malhotra-Kumar, S., Lammens, C., Coenen, S., Van Herck, K., & Goossens, H. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60235-9 · Cited by 545
Altenburg, J., de Graaff, C. S., Stienstra, Y., Sloos, J. H., van Haren, E. H. J., Koppers, R. J. H., van der Werf, T. S., & Boersma, W. G. (2013) · JAMA · doi:10.1001/jama.2013.1937 · Cited by 518
Brusselle, G. G., VanderStichele, C., Jordens, P., Deman, R., Slabbynck, H., Ringoet, V., Verleden, G., Demedts, I. K., Verhamme, K., Delporte, A., et al. (2013) · Thorax · doi:10.1136/thoraxjnl-2012-202698 · Cited by 477
Self-citationTresse, E., Salomons, F. A., Vesa, J., Bott, L. C., Kimonis, V., Yao, T.-P., Dantuma, N. P., & Taylor, J. P. (2010) · Autophagy · doi:10.4161/auto.6.2.11014 · Cited by 437
Amsden, G. W. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh519 · Cited by 409
Azithromycin Inhibits Quorum Sensing in Pseudomonas aeruginosa
Tateda, K., Comte, R., Péchère, J.-C., et al. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.6.1930-1933.2001 · Cited by 401
Felmingham, D., & Grüneberg, R. N. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/45.2.191 · Cited by 368
Anti-inflammatory activity of macrolide antibiotics
Michie, C. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)02441-3 · Cited by 356
Erythromycin is a motilin receptor agonist
Peeters, T., Matthijs, G., Depoortere, I., Cachet, T., Hoogmartens, J., & Vantrappen, G. (1989) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1989.257.3.g470 · Cited by 354
Multiple Antibiotics Exert Delayed Effects against the Plasmodium falciparum Apicoplast
Dahl, E. L., & Rosenthal, P. J. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00527-07 · Cited by 339
Azithromycin induces anti-viral responses in bronchial epithelial cells
Gielen, V., Johnston, S. L., & Edwards, M. R. (2010) · European Respiratory Journal · doi:10.1183/09031936.00095809 · Cited by 336
Anti-inflammatory effects of macrolide antibiotics
Čulić, O., Eraković, V., & Parnham, M. J. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01321-8 · Cited by 334
Self-citationSinusitis of odontogenic origin
Brook, I. (2006) · Otolaryngology–Head and Neck Surgery · doi:10.1016/j.otohns.2005.10.059 · Cited by 323
Azithromycin blocks autophagy and may predispose cystic fibrosis patients to mycobacterial infection
Renna, M., Schaffner, C., Brown, K., Shang, S., Tamayo, M. H., Hegyi, K., Grimsey, N. J., Cusens, D., Coulter, S., Cooper, J., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci46095 · Cited by 314
Anti-Inflammatory Activity of Macrolide Antibiotics
Ianaro, A., Ialenti, A., Maffia, P., Sautebin, L., Rombolà, L., Carnuccio, R., Iuvone, T., D’Acquisto, F., & Di Rosa, M. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35272-3 · Cited by 309
Maintenance Azithromycin Therapy for Bronchiolitis Obliterans Syndrome: Results of a Pilot Study
Gerhardt, S. G., McDyer, J. F., Girgis, R. E., Conte, J. V., Yang, S. C., & Orens, J. B. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200212-1424bc · Cited by 306
Macrolide antibiotics for cystic fibrosis
Southern, K. W., Barker, P. M., Solis-Moya, A., & Patel, L. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002203.pub4 · Cited by 298
Verleden, G. M., Vanaudenaerde, B. M., Dupont, L. J., & Van Raemdonck, D. E. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200601-071oc · Cited by 296
Self-citationClement, A. (2006) · Thorax · doi:10.1136/thx.2005.057950 · Cited by 292
Tait-Kamradt, A., Davies, T., Cronan, M., Jacobs, M. R., Appelbaum, P. C., & Sutcliffe, J. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.8.2118-2125.2000 · Cited by 281
LAU, C.-Y., & QURESHI, A. K. (2002) · Sexually Transmitted Diseases · doi:10.1097/00007435-200209000-00001 · Cited by 271
Vos, R., Vanaudenaerde, B. M., Verleden, S. E., De Vleeschauwer, S. I., Willems-Widyastuti, A., Van Raemdonck, D. E., Schoonis, A., Nawrot, T. S., Dupont, L. J., & Verleden, G. M. (2011) · European Respiratory Journal · doi:10.1183/09031936.00068310 · Cited by 268
Self-citationHoffmann, N., Lee, B., Hentzer, M., Rasmussen, T. B., Song, Z., Johansen, H. K., Givskov, M., & Høiby, N. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01011-06 · Cited by 267
Hodge, S., Hodge, G., Jersmann, H., Matthews, G., Ahern, J., Holmes, M., & Reynolds, P. N. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200711-1666oc · Cited by 258
Martin-Loeches, I., Lisboa, T., Rodriguez, A., Putensen, C., Annane, D., Garnacho-Montero, J., Restrepo, M. I., & Rello, J. (2010) · Intensive Care Medicine · doi:10.1007/s00134-009-1730-y · Cited by 254
Use of Azithromycin and Death from Cardiovascular Causes
Svanström, H., Pasternak, B., & Hviid, A. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1300799 · Cited by 254
Čulić, O., Eraković, V., Čepelak, I., Barišić, K., Brajša, K., Ferenčić, Ž., Galović, R., Glojnarić, I., Manojlović, Z., Munić, V., et al. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)02042-3 · Cited by 234
Self-citationRecent advances in the treatment of Pseudomonas aeruginosainfections in cystic fibrosis
Høiby, N. (2011) · BMC Medicine · doi:10.1186/1741-7015-9-32 · Cited by 234
Milberg, P., Eckardt, L., Bruns, H.-J., Biertz, J., Ramtin, S., Reinsch, N., Fleischer, D., Kirchhof, P., Fabritz, L., Breithardt, G., et al. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.037911 · Cited by 229
Macrolide antibiotics as immunomodulatory medications: Proposed mechanisms of action
Shinkai, M., Henke, M. O., & Rubin, B. K. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.11.001 · Cited by 227
Long-Term Azithromycin for Bronchiolitis Obliterans Syndrome After Lung Transplantation
Gottlieb, J., Szangolies, J., Koehnlein, T., Golpon, H., Simon, A., & Welte, T. (2008) · Transplantation · doi:10.1097/01.tp.0000295981.84633.bc · Cited by 218
den Heijer, C. D., van Bijnen, E. M., Paget, W. J., Pringle, M., Goossens, H., Bruggeman, C. A., Schellevis, F. G., & Stobberingh, E. E. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70036-7 · Cited by 216
Impact of macrolide therapy on mortality for patients with severe sepsis due to pneumonia
Restrepo, M. I., Mortensen, E. M., Waterer, G. W., Wunderink, R. G., Coalson, J. J., & Anzueto, A. (2009) · European Respiratory Journal · doi:10.1183/09031936.00054108 · Cited by 197
Giovanetti, E., Montanari, M. P., Mingoia, M., & Varaldo, P. E. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.8.1935 · Cited by 193
Videler, W. J., Badia, L., Harvey, R. J., Gane, S., Georgalas, C., van der Meulen, F. W., Menger, D. J., Lehtonen, M. T., Toppila‐Salmi, S. K., Vento, S. I., et al. (2011) · Allergy · doi:10.1111/j.1398-9995.2011.02693.x · Cited by 192
Azithromycin increases phagocytosis of apoptotic bronchial epithelial cells by alveolar macrophages
Hodge, S., Hodge, G., Brozyna, S., Jersmann, H., Holmes, M., & Reynolds, P. N. (2006) · European Respiratory Journal · doi:10.1183/09031936.06.00001506 · Cited by 190
Valery, P. C., Morris, P. S., Byrnes, C. A., Grimwood, K., Torzillo, P. J., Bauert, P. A., Masters, I. B., Diaz, A., McCallum, G. B., Mobberley, C., et al. (2013) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(13)70185-1 · Cited by 189
Azithromycin alters macrophage phenotype
Murphy, B. S., Sundareshan, V., Cory, T. J., Hayes, D., Anstead, M. I., & Feola, D. J. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn007 · Cited by 187
Khair, O., Devalia, J., Abdelaziz, M., Sapsford, R., & Davies, R. (1995) · European Respiratory Journal · doi:10.1183/09031936.95.08091451 · Cited by 184
Sakito, O., Kadota, J.-I., Kohno, S., Abe, K., Shirai, R., & Hara, K. (1996) · Respiration · doi:10.1159/000196514 · Cited by 184
Regulation of autophagy in mammals and its interplay with apoptosis
Fimia, G. M., & Piacentini, M. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0284-z · Cited by 181
Lipid signaling and the modulation of surface charge during phagocytosis
Yeung, T., & Grinstein, S. (2007) · Immunological Reviews · doi:10.1111/j.1600-065x.2007.00546.x · Cited by 181
Mena, L. A., Mroczkowski, T. F., Nsuami, M., & Martin, D. H. (2009) · Clinical Infectious Diseases · doi:10.1086/599033 · Cited by 180
Jenkins, S. G., Brown, S. D., & Farrell, D. J. (2008) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/1476-0711-7-1 · Cited by 170
Effect of clarithromycin and azithromycin on production of cytokines by human monocytes
Khan, A., Slifer, T., Araujo, F., & Remington, J. (1999) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(98)00091-0 · Cited by 167
Vanaudenaerde, B. M., Meyts, I., Vos, R., Geudens, N., De Wever, W., Verbeken, E. K., Van Raemdonck, D. E., Dupont, L. J., & Verleden, G. M. (2008) · European Respiratory Journal · doi:10.1183/09031936.00134307 · Cited by 163
Self-citationLong-term macrolide treatment for chronic respiratory disease
Spagnolo, P., Fabbri, L. M., & Bush, A. (2012) · European Respiratory Journal · doi:10.1183/09031936.00136712 · Cited by 161
Effect of Clarithromycin in Patients with Sepsis and Ventilator‐Associated Pneumonia
Giamarellos‐Bourboulis, E. J., Pechère, J., Routsi, C., Plachouras, D., Kollias, S., Raftogiannis, M., Zervakis, D., Baziaka, F., Koronaios, A., Antonopoulou, A., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/529439 · Cited by 158
Self-citationAzithromycin--review of key chemical, pharmacokinetic and microbiological features
Lode, H., Borner, K., Koeppe, P., & Schaberg, T. (1996) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/37.suppl_c.1 · Cited by 158
Antibiotics for Bacteremic Pneumonia
Metersky, M. L., Ma, A., Houck, P. M., & Bratzler, D. W. (2007) · Chest · doi:10.1378/chest.06-1426 · Cited by 158
Erythromycin, clarithromycin, and azithromycin: are the differences real?
Amsden, G. W. (1996) · Clinical Therapeutics · doi:10.1016/s0149-2918(96)80179-2 · Cited by 154
Aghai, Z. H., Kode, A., Saslow, J. G., Nakhla, T., Farhath, S., Stahl, G. E., Eydelman, R., Strande, L. F., Leone, P., & Rahman, I. (2007) · Pediatric Research · doi:10.1203/pdr.0b013e318142582d · Cited by 152
Bosnar, M., Kelnerić, Ž., Kos, V. M., Haber, V. E., & Parnham, M. J. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.6.2372-2377.2005 · Cited by 152
Self-citationAutophagy proteins in macroendocytic engulfment
Florey, O., & Overholtzer, M. (2012) · Trends in Cell Biology · doi:10.1016/j.tcb.2012.04.005 · Cited by 150
Ju, J.-S., & Weihl, C. C. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq157 · Cited by 143
Stamm, W. E. (1995) · JAMA · doi:10.1001/jama.274.7.545 · Cited by 142
Binder, A. M., Adjemian, J., Olivier, K. N., & Prevots, D. R. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201307-1200oc · Cited by 140
Azithromycin Blocks Neutrophil Recruitment in Pseudomonas Endobronchial Infection
Tsai, W. C., Rodriguez, M. L., Young, K. S., Deng, J. C., Thannickal, V. J., Tateda, K., Hershenson, M. B., & Standiford, T. J. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200402-200oc · Cited by 138
Pharmacokinetics of azithromycin in rats and dogs
Shepard, R. M., & Falkner, F. C. (1990) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/25.suppl_a.49 · Cited by 136
Azithromycin Reduces Exaggerated Cytokine Production by M1 Alveolar Macrophages in Cystic Fibrosis
Meyer, M., Huaux, F., Gavilanes, X., van den Brûle, S., Lebecque, P., Re, S. L., Lison, D., Scholte, B. J., Wallemacq, P. E., & Leal, T. (2009) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2008-0155oc · Cited by 133
Blood, Tissue, and Intracellular Concentrations of Azithromycin during and after End of Therapy
Matzneller, P., Krasniqi, S., Kinzig, M., Sörgel, F., Hüttner, S., Lackner, E., Müller, M., & Zeitlinger, M. A. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02011-12 · Cited by 131
Autophagy in the regulation of pathogen replication and adaptive immunity
Randow, F., & Münz, C. (2012) · Trends in Immunology · doi:10.1016/j.it.2012.06.003 · Cited by 130
Tetracycline treatment does not eradicate Mycoplasma genitalium
Falk, L., Fredlund, H., & Jensen, J. S. (2003) · Sexually Transmitted Infections · doi:10.1136/sti.79.4.318 · Cited by 128
van Delden, C., Köhler, T., Brunner‐Ferber, F., François, B., Carlet, J. M., & Pechère, J.-C. (2012) · Intensive Care Medicine · doi:10.1007/s00134-012-2559-3 · Cited by 122
Imamura, Y., Yanagihara, K., Mizuta, Y., Seki, M., Ohno, H., Higashiyama, Y., Miyazaki, Y., Tsukamoto, K., Hirakata, Y., Tomono, K., et al. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.9.3457-3461.2004 · Cited by 122
Anti-inflammatory effects of azithromycin in cystic fibrosis airway epithelial cells
Cigana, C., Nicolis, E., Pasetto, M., Assael, B. M., & Melotti, P. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.09.132 · Cited by 121
Azithromycin distinctively modulates classical activation of human monocytes in vitro
Vrančić, M., Banjanac, M., Nujić, K., Bosnar, M., Murati, T., Kos, V. M., Polančec, D., Belamarić, D., Mj, P., & Haber, V. E. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01576.x · Cited by 120
Self-citationAdvanced-generation macrolides: tissue-directed antibiotics
Amsden, G. W. (2001) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(01)00410-1 · Cited by 120
Novel Effects of Azithromycin on Tight Junction Proteins in Human Airway Epithelia
Ásgrímsson, V., Guðjónsson, Þ., Gudmundsson, G. H., & Baldursson, Ó. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.5.1805-1812.2006 · Cited by 120
PIACENTINI, G. L., Peroni, D. G., Bodini, A., Pigozzi, R., Costella, S., Loiacono, A., & Boner, A. L. (2007) · Allergy and Asthma Proceedings · doi:10.2500/aap.2007.28.2958 · Cited by 116
Moriya, S., Che, X., KOMATSU, S., ABE, A., KAWAGUCHI, T., Gotoh, A., Inazu, M., Tomoda, A., & Miyazawa, K. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.1870 · Cited by 112
Azithromycin in periodontal treatment: more than an antibiotic
Hirsch, R., Deng, H., & Laohachai, M. N. (2011) · Journal of Periodontal Research · doi:10.1111/j.1600-0765.2011.01418.x · Cited by 112
Azithromycin Reduces Gastroesophageal Reflux and Aspiration in Lung Transplant Recipients
Mertens, V., Blondeau, K., Pauwels, A., Farré, R., Vanaudenaerde, B. M., Vos, R., Verleden, G. M., Raemdonck, D. E. V., Dupont, L., & Sifrim, D. A. (2009) · Digestive Diseases and Sciences · doi:10.1007/s10620-009-0725-4 · Cited by 111
Self-citationEuropean Surveillance of Antimicrobial Consumption (ESAC): systemic antiviral use in Europe
Adriaenssens, N., Coenen, S., Kroes, A. C. M., Versporten, A., Vankerckhoven, V., Müller, A., Blix, H. S., Goossens, H., on behalf of the ESAC Project Group, Mittermayer, H., et al. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr190 · Cited by 111
Azithromycin Maintains Airway Epithelial Integrity during Pseudomonas aeruginosa Infection
Halldórsson, S., Guðjónsson, Þ., Gottfreðsson, M., Singh, P. K., Gudmundsson, G. H., & Baldursson, Ó. (2009) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2008-0357oc · Cited by 106
Macrolides Versus Azalides: A Drug Interaction Update
Amsden, G. W. (1995) · Annals of Pharmacotherapy · doi:10.1177/106002809502900913 · Cited by 105
The effect of azithromycin on reactive oxygen species in rosacea
Bakar, Ö., Demirçay, Z., Yüksel, M., Haklar, G., & Sanısoğlu, Y. (2007) · Clinical and Experimental Dermatology · doi:10.1111/j.1365-2230.2006.02322.x · Cited by 105
Kezerashvili, A., Khattak, H. K., Barsky, A. A., Nazari, R., & Fisher, J. D. (2007) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-007-9124-y · Cited by 105
Azithromycin attenuates airway inflammation in a mouse model of viral bronchiolitis
Beigelman, A., Mikols, C. L., Gunsten, S. P., Cannon, C. L., Brody, S. L., & Walter, M. J. (2010) · Respiratory Research · doi:10.1186/1465-9921-11-90 · Cited by 104
Feola, D. J., Garvy, B. A., Cory, T. J., Birket, S. E., Hoy, H., Hayes, D., & Murphy, B. S. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01424-09 · Cited by 104
Azithromycin reduces spontaneous and induced inflammation in ΔF508 cystic fibrosis mice
Legssyer, R., Huaux, F., Lebacq, J., Delos, M., Marbaix, É., Lebecque, P., Lison, D., Scholte, B. J., Wallemacq, P. E., & Leal, T. (2006) · Respiratory Research · doi:10.1186/1465-9921-7-134 · Cited by 104
A Novel Macrolide Solithromycin Exerts Superior Anti-inflammatory Effect via NF-κB Inhibition
Kobayashi, Y., Wada, H., Rossios, C., Takagi, D., Higaki, M., Mikura, S., Goto, H., Barnes, P. J., & Ito, K. (2013) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.200733 · Cited by 103
Broad, J., & Sanger, G. J. (2012) · British Journal of Pharmacology · doi:10.1111/bph.12077 · Cited by 102
Navarro-Xavier, R., Newson, J., Silveira, V. L. F., Farrow, S. N., Gilroy, D. W., & Byström, J. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0902866 · Cited by 100
Li, H., Liu, D., Chen, L., Zhao, Q., Yu, Y., Ding, J., Miao, L., Xiao, Y., Cai, H., Zhang, D., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02067-13 · Cited by 100
Maternal and transplacental pharmacokinetics of azithromycin
Ramsey, P. S., Vaules, M. B., Vasdev, G., Andrews, W. W., & Ramin, K. D. (2003) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2003.141 · Cited by 100
Gebre, T., Ayele, B., Zerihun, M., Genet, A., Stoller, N. E., Zhou, Z., House, J. I., Yu, S. N., Ray, K. J., Emerson, P. M., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)61515-8 · Cited by 100
Macrolide antibiotics for cystic fibrosis
Southern, K. W., Barker, P., Solís-Moya, A., & Patel, L. B. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002203.pub3 · Cited by 98
Ribeiro, C. M. P., Hurd, H. L., Wu, Y., Martino, M. E. B., Jones, L. C., Brighton, B. K., Boucher, R. C., & O’Neal, W. K. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005806 · Cited by 96
Parnham, M. J., Čulić, O., Haber, V. E., Kos, V. M., Popović‐Grle, S., Barišić, K., Bosnar, M., Brajša, K., Čepelak, I., Čužić, S., et al. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.05.023 · Cited by 95
Self-citationEffects of long-term low-dose azithromycin in patients with non-CF bronchiectasis
Anwar, G. A., Bourke, S. C., Afolabi, G., Middleton, P. G., Ward, C., & Rutherford, R. (2008) · Respiratory Medicine · doi:10.1016/j.rmed.2008.06.005 · Cited by 95
The Expanded Spectrum of Bartonellosis in Children
Massei, F., Gori, L., Macchia, P., & Maggiore, G. (2005) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2005.06.001 · Cited by 93
Kneyber, M. C. J., van Woensel, J. B. M., Uijtendaal, E. V., Uiterwaal, C. S. P. M., & Kimpen, J. L. L. (2007) · Pediatric Pulmonology · doi:10.1002/ppul.20748 · Cited by 91
Koch, C. C. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/46.1.19 · Cited by 90
Bosnar, M., Bošnjak, B., Čužić, S., Hrvačić, B., Marjanović, N., Glojnarić, I., Čulić, O., Parnham, M. J., & Haber, V. E. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.155838 · Cited by 89
Self-citationMacrolide Resistance from the Ribosome Perspective
Franceschi, F. J., Kanyo, Z. F., Sherer, E. C., & Sutcliffe, J. A. (2004) · Current Drug Targets - Infectious Disorders · doi:10.2174/1568005043340740 · Cited by 87
Montenez, J. P., Françoise Van Bambeke, A., Piret, J., Brasseur, R., Tulkens, P. M., & Mingeot-Leclercq, M. P. (1999) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1999.8632 · Cited by 86
Spyridaki, A., Raftogiannis, M., Antonopoulou, A., Τσαγανός, Θ., Routsi, C., Baziaka, F., Karagianni, V., Mouktaroudi, M., Koutoukas, P., Πελεκάνου, Α., et al. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05798-11 · Cited by 84
Self-citationHodge, S. J., & Reynolds, P. N. (2012) · Respirology · doi:10.1111/j.1440-1843.2012.02135.x · Cited by 83
Long-term azithromycin use in patients with chronic obstructive pulmonary disease and tracheostomy
Blasi, F., Bonardi, D. R., Aliberti, S., Tarsia, P., Confalonieri, M., Amir, O., Carone, M., Marco, F. D., Centanni, S., & Guffanti, E. E. (2009) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2009.12.002 · Cited by 82
Rohof, W. O., Bennink, R. J., de Ruigh, A. A., Hirsch, D. P., Zwinderman, A. H., & Boeckxstaens, G. E. (2012) · Gut · doi:10.1136/gutjnl-2011-300926 · Cited by 82
Azithromycin for treating uncomplicated malaria
van Eijk, A. M., & Terlouw, D. J. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006688.pub2 · Cited by 79
Wilms, E. B., Touw, D. J., & Heijerman, H. G. M. (2006) · Therapeutic Drug Monitoring · doi:10.1097/01.ftd.0000195617.69721.a5 · Cited by 79
Cameron, E. J., McSharry, C. P., Chaudhuri, R., Farrow, S. N., & Thomson, N. C. (2012) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2012.03979.x · Cited by 77
Drug interactions during therapy with three major groups of antimicrobial agents
Shakeri‐Nejad, K., & Stahlmann, R. (2006) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.7.6.639 · Cited by 77
Macrolide effects on the prevention of COPD exacerbations
Yamaya, M., Azuma, A., Takizawa, H., Kadota, J., Tamaoki, J., & Kudoh, S. (2012) · European Respiratory Journal · doi:10.1183/09031936.00208011 · Cited by 77
Tyteca, D. (2002) · Experimental Cell Research · doi:10.1006/excr.2002.5613 · Cited by 75
Carlier, M.-B., Garcı́a, I., Montenez, J. P., Tulkens, P. M., & Piret, J. (1994) · PubMed · Cited by 74
Esposito, S., Bosis, S., Faelli, N., Begliatti, E., Droghetti, R., Tremolati, E., Porta, A. S., Blasi, F., & Principi, N. (2005) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000160949.99560.8d · Cited by 73
Azithromycin Attenuates Airway Inflammation in a Noninfectious Mouse Model of Allergic Asthma
Beigelman, A., Gunsten, S. P., Mikols, C. L., Vidavsky, I., Cannon, C. L., Brody, S. L., & Walter, M. J. (2009) · CHEST Journal · doi:10.1378/chest.08-3056 · Cited by 72
Marjanović, N., Bosnar, M., Michielin, F., Willé, D. R., Anić-Milić, T., Čulić, O., Popović‐Grle, S., Bogdan, M., Parnham, M. J., & Haber, V. E. (2011) · Pharmacological Research · doi:10.1016/j.phrs.2011.02.001 · Cited by 71
Self-citationNujić, K., Banjanac, M., Kos, V. M., Polančec, D., & Haber, V. E. (2012) · Cellular Immunology · doi:10.1016/j.cellimm.2012.09.007 · Cited by 70
Self-citationDisposition of oral azithromycin in humans*
Luke, D. R., & Foulds, G. H. (1997) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(97)90098-9 · Cited by 69
Champney, W. S., & Burdine, R. (1998) · Current Microbiology · doi:10.1007/s002849900290 · Cited by 69
Azithromycin reduces pulmonary fibrosis in a bleomycin mouse model
Wuyts, W. A., Willems, S., Vos, R., Vanaudenaerde, B. M., Vleeschauwer, S. I. D., Rinaldi, M., Vanhooren, H. M., Geudens, N., Verleden, S. E., Demedts, M., et al. (2010) · Experimental Lung Research · doi:10.3109/01902148.2010.492895 · Cited by 69
Self-citationLin, H.-C., Wang, C., LIU, C.-Y., Yu, C., & Kuo, H. ‐. (2000) · Respiratory Medicine · doi:10.1053/rmed.1999.0781 · Cited by 68
Retrovirus classification and cell interactions
Weiss, R. A. (1996) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/37.suppl_b.1 · Cited by 68
Degradative transport of cationic amphiphilic drugs across phospholipid bilayers
Baciu, M., Sébaï, S. C., Ces, O., Mulet, X., Clarke, J. A., Shearman, G. C., Law, R. V., Templer, R. H., Plisson, C., Parker, C. A., et al. (2006) · Philosophical Transactions of the Royal Society A Mathematical Physical and Engineering Sciences · doi:10.1098/rsta.2006.1842 · Cited by 67
Pitsouni, E. I., Iavazzo, C., Athanasiou, S., & Falagas, M. E. (2007) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2007.04.015 · Cited by 67
Mannose 6-phosphate receptors, Niemann-Pick C2 protein, and lysosomal cholesterol accumulation
Willenborg, M., Schmidt, C. K., Braun, P., Landgrebe, J., FIGURA, K. V., Säftig, P., & Eskelinen, E. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m500131-jlr200 · Cited by 66
Macrolide resistance: an increasing concern for treatment failure in children
Jacobs, M. R., & Johnson, C. E. (2003) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200308001-00004 · Cited by 65
Mizunoe, S., Kadota, J., Tokimatsu, I., Kishi, K., Nagai, H., & Nasu, M. (2004) · International Immunopharmacology · doi:10.1016/j.intimp.2004.05.011 · Cited by 63
Role of long term antibiotics in chronic respiratory diseases
Babu, K. S., Kastelik, J. A., & Morjaria, J. (2013) · Respiratory Medicine · doi:10.1016/j.rmed.2013.02.009 · Cited by 63
Modeling Cellular Pharmacokinetics of 14- and 15-Membered Macrolides with Physicochemical Properties
Stepanić, V., Koštrun, S., Malnar, I., Hlevnjak, M., Butković, K., Ćaleta, I., Dukši, M., Kragol, G., Stegić, O. M., Mikac, L., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm101317f · Cited by 60
Bambeke, F. V., Montenez, J.-P., Piret, J., et al. (1996) · European Journal of Pharmacology · doi:10.1016/s0014-2999(96)00552-3 · Cited by 59
Mencarelli, A., Distrutti, E., Renga, B., Cipriani, S., Palladino, G., Booth, C. E., Tudor, G. L., Guse, J., Hahn, U. K., Burnet, M. W. M., et al. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.04.036 · Cited by 58
Kos, V. M., Kelnerić, Ž., Mikac, L., & Haber, V. E. (2010) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2010.05.016 · Cited by 58
Self-citationBartold, P. M., BOIS, A. H. D., Gannon, S. C., Haynes, D. R., & Hirsch, R. (2013) · Inflammopharmacology · doi:10.1007/s10787-012-0165-1 · Cited by 58
Paolo, A. D., Barbara, C., Chella, A., Angeletti, C. A., & Tacca, M. D. (2002) · Pharmacological Research · doi:10.1016/s1043661802002384 · Cited by 57
Tyteca, D., Schanck, A. N., Dufrêne, Y. F., Deleu, M., Courtoy, P. J., Tulkens, P. M., & Mingeot-Leclercq, M. P. (2003) · The Journal of Membrane Biology · doi:10.1007/s00232-002-1076-7 · Cited by 56
Long-term, low-dose erythromycin in bronchiectasis subjects with frequent infective exacerbations
Serisier, D. J., & Martin, M. L. (2011) · Respiratory Medicine · doi:10.1016/j.rmed.2011.01.009 · Cited by 55
Ikeda, K., Hirayama, M., Hirota, Y., Asa, E., Seki, J., & Tanaka, Y. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.09.121 · Cited by 54
Azithromycin increases survival and reduces lung inflammation in cystic fibrosis mice
Tsai, W. C., Hershenson, M. B., Zhou, Y., & Sajjan, U. S. (2009) · Inflammation Research · doi:10.1007/s00011-009-0015-9 · Cited by 54
Thorpe, E. M., Stamm, W. E., Hook, E. W., Gall, S. A., Jones, R. B., Henry, K., Whitworth, G., & Johnson, R. B. (1996) · Sexually Transmitted Infections · doi:10.1136/sti.72.2.93 · Cited by 54
Champney, W. S., Tober, C. L., & Burdine, R. (1998) · Current Microbiology · doi:10.1007/s002849900402 · Cited by 53
Azithromycin and risk of sudden cardiac death: Guilty as charged or falsely accused?
Giudicessi, J. R., & Ackerman, M. J. (2013) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.80a.13077 · Cited by 51
Pharmacokinetic Properties of Azithromycin in Pregnancy
Salman, S., Rogerson, S. J., Kose, K., Griffin, S., Gomorrai, S., Baiwog, F., Winmai, J., Kandai, J., Karunajeewa, H., O’Halloran, S., et al. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00771-09 · Cited by 51
Polančec, D. S., Kos, V. M., Banjanac, M., Vrančić, M., Čužić, S., Belamarić, D., Parnham, M. J., Polančec, D., & Haber, V. E. (2011) · Journal of Leukocyte Biology · doi:10.1189/jlb.1210655 · Cited by 51
Self-citationMechanisms of resistance to macrolides, lincosamides, and ketolides
Sutcliffe, J. A., & Leclercq, R. (2002) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-8105-0_17 · Cited by 50
Lutz, L., Pereira, D. C., Paiva, R. M., Zavascki, A. P., & Barth, A. L. (2012) · BMC Microbiology · doi:10.1186/1471-2180-12-196 · Cited by 50
Antibiotics as Anti-Inflammatory and Immunomodulatory Agents
Rubin, B. K., & Tamaoki, J. (2005) · Birkhäuser-Verlag eBooks · doi:10.1007/b137084 · Cited by 50
Coloma, P. M., Schuemie, M. J., Trifirò, G., Furlong, L. I., van Mulligen, E. M., Bauer‐Mehren, A., Avillach, P., Kors, J. A., Sanz, F., Mestres, J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072148 · Cited by 49
Carević, O., & Djokić, S. (1988) · Inflammation Research · doi:10.1007/bf01969103 · Cited by 48
Köhler, T., Dumas, J.-L., & van Delden, C. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00613-07 · Cited by 47
Role of extracellular calcium in in vitro uptake and intraphagocytic location of macrolides
Mtairag, E. M., Abdelghaffar, H., Douhet, C., et al. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.8.1676 · Cited by 47
Bermejo-Martín, J. F., Kelvin, D. J., Bouza, J. M. E., Castrodeza, J., & de Lejarazu, R. O. (2009) · The Journal of Infection in Developing Countries · doi:10.3855/jidc.18 · Cited by 47
Morinaga, Y., Yanagihara, K., Miyashita, N., Seki, M., Izumikawa, K., Kakeya, H., Yamamoto, Y., Mukae, H., Yamada, Y., Kohno, S., et al. (2009) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2009.08.004 · Cited by 46
MURRAY, J. J., Emparanza, P., Lesinskas, E., et al. (2005) · Otolaryngology · doi:10.1016/j.otohns.2005.04.020 · Cited by 45
A Novel Efflux System in Inducibly Erythromycin-Resistant Strains of Streptococcus pyogenes
Giovanetti, E., Brenciani, A., Burioni, R., & Varaldo, P. E. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.12.3750-3755.2002 · Cited by 44
Yamauchi, K., Shibata, Y., Kimura, T., Abe, S., Inoue, S., Osaka, D., Sato, M., Igarashi, A., & Kubota, I. (2009) · International Journal of Biological Sciences · doi:10.7150/ijbs.5.667 · Cited by 44
Henry, D. C., Riffer, E., Sokol, W. N., Chaudry, N. I., & Swanson, R. N. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.9.2770-2774.2003 · Cited by 43
Necrotizing glomerulonephritis caused by Bartonella henselae endocarditis
Bookman, I. D., Scholey, J. W., Jassal, S. V., Lajoie, G., & Herzenberg, A. M. (2004) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2003.10.027 · Cited by 42
Dias, R. P. M., & Caniça, M. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh469 · Cited by 42
Garver, E. M., Hugger, E. D., Shearn, S. P., Rao, A., Dawson, P. A., Davis, C. B., & Han, C. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.022285 · Cited by 40
Emerging drugs for the treatment of sepsis
Kotsaki, A., & Giamarellos‐Bourboulis, E. J. (2012) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2012.697151 · Cited by 40
Self-citationYamada, K., Yanagihara, K., Kaku, N., Harada, Y., Migiyama, Y., Nagaoka, K., Morinaga, Y., Nakamura, S., Imamura, Y., Miyazaki, T., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00457-13 · Cited by 40
Meloni, F., Solari, N., Morosini, M., Cascina, A., Oggionni, T., Bini, F., Viganò, M., & Maria, F. A. (2011) · Clinical Transplantation · doi:10.1111/j.1399-0012.2011.01435.x · Cited by 39
Araki, N., Yanagihara, K., Morinaga, Y., Yamada, K., Nakamura, S., Yamada, Y., Kohno, S., & Kamihira, S. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.06.056 · Cited by 39
Effect of azithromycin on natural killer cell function
Lin, S., Yan, D., Lee, W., Kuo, M., Hsiao, H.-S., & Lee, P.-Y. (2012) · International Immunopharmacology · doi:10.1016/j.intimp.2012.02.013 · Cited by 39
Rubinstein, E. (2003) · International Journal of Infectious Diseases · doi:10.1016/s1201-9712(03)90063-4 · Cited by 39
Skalsky, K., Yahav, D., Lador, A., Eliakim‐Raz, N., Leibovici, L., & Paul, M. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2012.03838.x · Cited by 38
Asakura, E., Nakayama, H., Sugie, M., et al. (2003) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2003.11.035 · Cited by 38
Shinkai, M., Tamaoki, J., Kobayashi, H., Kanoh, S., Motoyoshi, K., Kute, T., & Rubin, B. K. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.5.1738-1744.2006 · Cited by 38
Azithromycin, a lysosomotropic antibiotic, impairs fluid-phase pinocytosis in cultured fibroblasts
Tyteca, D., Smissen, P. V. D., Françoise Van Bambeke, A., Leys, K., Tulkens, P. M., Courtoy, P. J., & Mingeot‐Leclercq, M. (2001) · European Journal of Cell Biology · doi:10.1078/0171-9335-00180 · Cited by 37
Ishimoto, H., Mukae, H., Sakamoto, N., Amenomori, M., Kitazaki, T., Imamura, Y., Fujita, H., Ishii, H., Nakayama, S., Yanagihara, K., et al. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn427 · Cited by 36
Dinos, G. P., Michelinaki, M., & Kalpaxis, D. L. (2001) · Molecular Pharmacology · doi:10.1124/mol.59.6.1441 · Cited by 36
Ambroggio, L., Taylor, J. A., Tabb, L. P., et al. (2012) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2012.06.067 · Cited by 35
Terao, H., Asano, K., Kanai, K., Kyo, Y., Watanabe, S., Hisamitsu, T., & Suzaki, H. (2003) · Mediators of Inflammation · doi:10.1080/09629350310001599620 · Cited by 35
Kudoh, S. (2004) · The American Journal of Medicine Supplements · doi:10.1016/j.amjmed.2004.07.024 · Cited by 33
Wilson, B. Z., Anzueto, A., Restrepo, M. I., Pugh, M. J., & Mortensen, E. M. (2012) · Critical Care Medicine · doi:10.1097/ccm.0b013e31825151a8 · Cited by 33
Probing the Interactions of Macrolide Antibiotics with Membrane-Mimetics by NMR Spectroscopy
Kosol, S., Schrank, E., Krajačić, M. B., Wagner, G. E., Meyer, N. H., Göbl, C., Rechberger, G. N., Zangger, K., & Novak, P. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300647f · Cited by 33
Ikegaya, S., Inai, K., Iwasaki, H., Naiki, H., & Ueda, T. (2009) · Journal of Chemotherapy · doi:10.1179/joc.2009.21.4.396 · Cited by 29
Fleet, J. L., Shariff, S. Z., Bailey, D. G., Gandhi, S., Juurlink, D. N., Nash, D. M., Mamdani, M., Gomes, T., Patel, A. M., & Garg, A. X. (2013) · BMJ Open · doi:10.1136/bmjopen-2013-002857 · Cited by 28
Azithromycin fails to reduce inflammation in cystic fibrosis airway epithelial cells
Saint‐Criq, V., Ruffin, M., Rebeyrol, C., Guillot, L., Jacquot, J. P., Clément, A., & Tabary, O. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.10.027 · Cited by 28
Azithromycin Protects against Hyperoxic Lung Injury in Neonatal Rats
Ballard, H. O., Bernard, P. A., Qualls, J. E., Everson, W. V., & Shook, L. A. (2007) · Journal of Investigative Medicine · doi:10.2310/6650.2007.00011 · Cited by 26
Leaky lysosomes in lung transplant macrophages: azithromycin prevents oxidative damage
Persson, H. L., Vainikka, L. K., Sege, M., Wennerström, U., Dam-Larsen, S., & Persson, J. (2012) · Respiratory Research · doi:10.1186/1465-9921-13-83 · Cited by 24
In vivo administration of azithromycin affects lymphocyte activity in vitro
Tomažič, J., Kotnik, V., & Wraber, B. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.9.1786 · Cited by 22
Fernandez, A. D., Elmore, M. K., & Metzger, D. W. (2004) · The Journal of Infectious Diseases · doi:10.1086/425038 · Cited by 21
Tong, J., Liu, Z.-C., & Dao-xin, W. (2011) · Immunology Letters · doi:10.1016/j.imlet.2011.04.001 · Cited by 20
Vanaudenaerde, B. M., Vos, R., Meyts, I., Vleeschauwer, S. D., Verleden, S. E., Widyastuti-Willems, A., Wuyts, W. A., Raemdonck, D. E. V., Hoet, P., Dupont, L., et al. (2008) · Inflammation & Allergy - Drug Targets · doi:10.2174/187152808786848414 · Cited by 20
Self-citationCuratolo, W. J., Liu, P., Johnson, B., et al. (2011) · Pharmaceutical Research · doi:10.1007/s11095-011-0386-9 · Cited by 19
Efficacy of azithromycin in preventing lethal graft-versus-host disease
Iwamoto, S., Azuma, E., Kumamoto, T., Hirayama, M., Yoshida, T., Ito, M., Amano, K., Ido, M., & Komada, Y. (2012) · Clinical & Experimental Immunology · doi:10.1111/cei.12023 · Cited by 18
Wang, P. (2010) · Journal of Pharmacological Sciences · doi:10.1254/jphs.09r25fm · Cited by 18
Nujić, K., Smith, M., Lee, M., Belamarić, D., Tomašković, L., Alihodžić, S., Malnar, I., Polančec, D., Schneider, K., & Haber, V. E. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.12.022 · Cited by 17
Self-citationDumitrescu, T. P., Anić-Milić, T., Oreskovic, K., Padovan, J., Brouwer, K. L. R., Zuo, P., & Schmith, V. D. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02430-12 · Cited by 17
Effects of macrolides on proinflammatory epitops on endothelial cells in vitro
Millrose, M., Kruse, M., Flick, B., & Stahlmann, R. (2008) · Archives of Toxicology · doi:10.1007/s00204-008-0388-5 · Cited by 16
Cited by
Antibiotic resistance in microbes: History, mechanisms, therapeutic strategies and future prospects
Uddin, T. M., Chakraborty, A. J., Khusro, A., Zidan, B. R. M., Mitra, S., Emran, T. B., Dhama, K., Ripon, M. K. H., Gajdács, M., Sahibzada, M. U. K., et al. (2021) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2021.10.020 · Cited by 1,311
Gibson, P. G., Yang, I. A., Upham, J. W., Reynolds, P. N., Hodge, S., James, A. L., Jenkins, C., Peters, M. J., Marks, G. B., Baraket, M., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31281-3 · Cited by 662
Lappin, M. R., Blondeau, J., Boothe, D., Breitschwerdt, E. B., Guardabassi, L., Lloyd, D. H., Papich, M. G., Rankin, S. C., Sykes, J. E., Turnidge, J., et al. (2017) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.14627 · Cited by 374
The Natural Product Curcumin as an Antibacterial Agent: Current Achievements and Problems
Dai, C., Lin, J., Li, H., Shen, Z., Wang, Y., Velkov, T., & Shen, J. (2022) · Antioxidants · doi:10.3390/antiox11030459 · Cited by 318
The Immunomodulatory Effects of Macrolides—A Systematic Review of the Underlying Mechanisms
Zimmermann, P., Ziesenitz, V. C., Curtis, N., & Ritz, N. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00302 · Cited by 303
Metadata
- Authors
- Parnham, M. J., Haber, V. E., Giamarellos-Bourboulis, E. J., Perletti, G., Verleden, G. M., & Vos, R.
- Venue
- Pharmacology & Therapeutics
- Publisher
- Elsevier BV
- Published
- 2014-08
- Volume
- 143
- Issue
- 2
- Pages
- 225-245
- ISSN
- 0163-7258 (ISSN-L)
- OpenAlex
- W2056406352
- Cited by
- 661
- References
- 208
- FWCI
- 21.21
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.